Back to Search
Start Over
Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging
- Source :
- PLoS Pathogens, PLoS Pathogens, Vol 13, Iss 6, p e1006430 (2017)
- Publication Year :
- 2017
-
Abstract
- While HSV-2 typically causes genital lesions, HSV-1 is increasingly the cause of genital herpes. In addition, neonatal HSV infections are associated with a high rate of mortality and HSV-2 may increase the risk for HIV or Zika infections, reinforcing the need to develop an effective vaccine. In the GSK Herpevac trial, doubly sero-negative women were vaccinated with a truncated form of gD2 [gD2(284t)], then examined for anti-gD serum titers and clinical manifestations of disease. Surprisingly, few vaccinees were protected against genital HSV-2 but 86% were protected from genital HSV-1. These observations suggest that subtle differences in gD structure might influence a protective response. To better understand the antigenic structure of gD and how it impacts a protective response, we previously utilized several key anti-gD monoclonal antibodies (mAbs) to dissect epitopes in vaccinee sera. Several correlations were observed but the methodology limited the number of sera and mAbs that could be tested. Here, we used array-based surface plasmon imaging (SPRi) to simultaneously measure a larger number of protein-protein interactions. We carried out cross-competition or “epitope binning” studies with 39 anti-gD mAbs and four soluble forms of gD, including a form [gD2(285t)] that resembles the Herpevac antigen. The results from these experiments allowed us to organize the mAbs into four epitope communities. Notably, relationships within and between communities differed depending on the form of gD, and off-rate analysis suggested differences in mAb-gD avidity depending on the gD serotype and length. Together, these results show that gD1 and gD2 differ in their structural topography. Consistent with the Herpevac results, several mAbs that bind both gD1 and gD2 neutralize only HSV-1. Thus, this technology provides new insights into the antigenic structure of gD and provides a rationale as to how vaccination with a gD2 subunit may lead to protection from HSV-1 infection.<br />Author summary Understanding the complex steps of herpes simplex virus (HSV) entry into susceptible cells is key for developing an effective vaccine to prevent clinical disease and control recurrences of this important human pathogen. For either serotype (HSV-1 or HSV-2), it is the interaction of glycoprotein D (gD) with receptor that initiates the cascade of events to begin infection. Importantly, gD stimulates high titers of virus-neutralizing antibodies that predict its importance in a protective response. Many HSV vaccines under development center around gD. In one recent clinical trial, subjects vaccinated with gD2 were protected against HSV-1 genital infection but not HSV-2, leading us to address how type specificity affects the antigenic topography of gD. Using a large panel of monoclonal antibodies (mAbs), we employed a new high-throughput, array-based approach to organize the mAbs into communities. Relationships within and between communities differed depending on the isotype and length of gD, suggesting significant differences in the epitope topography. We found that a subset of mAbs bound both gD1 and gD2 yet only neutralized HSV-1, possibly accounting for the anomalous results of the clinical trial. This new technology has proven to yield significant insights about how different regions of gD contribute to immune responses.
- Subjects :
- 0301 basic medicine
Proteomics
Physiology
Herpesvirus 2, Human
Herpesvirus 1, Human
medicine.disease_cause
Antibodies, Viral
Pathology and Laboratory Medicine
Biochemistry
Epitope
Binding Analysis
Viral Envelope Proteins
Immune Physiology
Medicine and Health Sciences
lcsh:QH301-705.5
Antigens, Viral
Vaccines
Immune System Proteins
Crystallography
biology
Physics
Condensed Matter Physics
3. Good health
Vaccination
Infectious Diseases
Medical Microbiology
Herpes Simplex Virus-2
Viral Pathogens
Physical Sciences
Viruses
Crystal Structure
Antibody
Pathogens
Research Article
lcsh:Immunologic diseases. Allergy
Herpesviruses
Infectious Disease Control
medicine.drug_class
030106 microbiology
Immunology
Herpesvirus Vaccines
Monoclonal antibody
Research and Analysis Methods
Microbiology
Peptide Mapping
Antibodies
03 medical and health sciences
Antigen
Antigen Isotypes
Virology
Epitope binning
Genetics
medicine
Animals
Humans
Solid State Physics
Avidity
Antigens
Molecular Biology
Microbial Pathogens
Chemical Characterization
Organisms
Biology and Life Sciences
Proteins
Herpes Simplex
Surface Plasmon Resonance
Antibodies, Neutralizing
High-Throughput Screening Assays
Herpes Simplex Virus
030104 developmental biology
Herpes simplex virus
lcsh:Biology (General)
biology.protein
Parasitology
lcsh:RC581-607
DNA viruses
Subjects
Details
- ISSN :
- 15537374
- Volume :
- 13
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- PLoS pathogens
- Accession number :
- edsair.doi.dedup.....cfb85b1b5d07b4112288a2eb2a448fbd